Ergoteles LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Ergoteles LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $194,771 - $343,972	-4,916 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $285,570 - $405,619	4,916 New	4,916 $326,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $1.61 Million - $2.34 Million	-27,587 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$62.15 - $90.32 $1.71 Million - $2.49 Million	27,587 New	27,587 $2.29 Million
Q4 2020 Feb 11, 2021	SELL	$43.82 - $85.37 $254,156 - $495,146	-5,800 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$33.21 - $51.27 $192,618 - $297,366	5,800 New	5,800 $250,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.76B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.